Delivery Order SPE2DB22D1017-SPE2DB24FF4LH
- Not listed
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $2,184.03 fixed-price contract is for the supply of M-M-R II vaccine vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $6,522.37 to provide M-M-R II vaccine vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a global pharmaceutical and medical supply distributor, to provide M-M-R II vaccine vials. The contract has a firm fixed price of $3,435.87 and a period of performance through March 25, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of M-M-R II vaccine vials. The contract has a ceiling value of $2,713.76 and a period of performance through March 29, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that has a potential value of $999,999,999.00 and runs...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $6,858.65, is for the delivery of M-M-R II vaccine vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II VACCINE VIALS. The contract has a completion date of February 8, 2024 and a potential value of $1,024.76. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $24,594.24 to supply M-M-R II vaccine vials. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,574.46 and a completion date of September 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $30,556.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of M-M-R II vaccine vials and has a period of performance through April 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to provide a comprehensive range of pharmaceutical products...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $1,120.02 and a completion date of June 27, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4LHDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, through its Corporate Office division, to provide M-M-R II vaccine vials. The contract has a ceiling value of $1,313.60 and a performance period through March 19, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations were used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/18/24 |